CENPE and cancer: Additionally, a study by Yoshizawa et al. found that the anti-proliferative effects of GSK923295 were greater in tetraploid compared to diploid HAP1 leukemia cells, suggesting that CENPE inhibitor cytotoxicity could be restricted to aneuploid tumours or cancers with CIN [134].